Zhaolei Zeng

27PUBLICATIONS
95CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 05, 2026
PLA1A Inhibition Enhances Chemoimmunotherapy Efficacy by Blocking Immunosuppressive Macrophage Polarization in Colorectal Cancer.

|Mar 12, 2026
Peritumoural adipose tissue promotes ferroptosis resistance by 3-hydroxykynurenine-mediated suppression of ferritinophagy.

Yan-Yu Zhang, Yi Han, Yue-Tao Tan

|Mar 02, 2026
Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer Chemoimmunotherapy.

Zheng-Yu Qian, Yuqing Deng, Mian Xi

|Jan 18, 2026
The AHCY-adenosine complex rewires mRNA methylation to enhance fatty acid biosynthesis and tumorigenesis.

Kun Liao, Fen Cao, Chen Wei

|Nov 14, 2025
A preserved TGFβ cytostatic response through DLD-mediated metabolic modulation undermines anti-TGFβ therapy in gastric cancer.

Yi-Qian Pan, Yi Han, Zheng-Yu Qian

|Jul 14, 2025
FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors.

Jiahuan Lu, Thomas Ting-Hei Chan, Yun Wang

Pageof 5

Frequent Collaborators

20 joint publications

Rui-Hua Xu

14 joint publications

Huai-Qiang Ju

13 joint publications

Zexian Liu

8 joint publications

Qi Zhao